Health / Medical Topics |
Vatalanib Succinate
The succinate salt of vatalanib, an anilinophthalazine derivative, with antineoplastic activity. Vatalanib binds to and inhibits the protein kinase domain of vascular endothelial growth factor receptors 1 and 2; both receptor tyrosine kinases are involved in angiogenesis. This agent also binds to and inhibits related receptor tyrosine kinases, including platelet-derived growth factor (PDGF) receptor, c-Kit, and c-Fms. (NCI Thesaurus)
YOU MAY ALSO LIKE
A substance that is being studied in the treatment of cancer. It belongs to the families of drugs called protein tyrosine kinase…
The largest muscle in the quadriceps femoris that is responsible for extending and stabilizing the knee.
Human VASP wild-type allele is located in the vicinity of 19q13.32 and is approximately 20 kb in length. This allele, which encodes…
This gene is involved in both cell adhesion and motility.
Loss of consciousness due to a reduction in blood pressure that is associated with an increase in vagal tone and peripheral…
Sudden drop of the blood pressure, bradycardia, and peripheral vasodilation that may lead to loss of consciousness. It results from an increase…